Raia Drogasil S/A banner

Intrinsic Value

The intrinsic value of Raia Drogasil S/A (RADLY) under the Base Case is 4.45 USD per share. Compared with the current market price of 2.7 USD, the stock appears Undervalued by 39% .

The intrinsic value is the average of valuations using the DCF method and multiples.

Do our valuations actually work? See backtest results .

RADLY Intrinsic Value
$4.45
Undervaluation 39%
Intrinsic Value
Price $2.7
Alert me when RADLY is below its intrinsic value
Today $2.67 · 1.0% below the current price

RADLY is cheaper than usual. It was this cheap or cheaper on less than 1% of days in the past 5 years.

Alternatives to RADLY

Fundamental Analysis

What Raia Drogasil S/A Does

Retail Consumer Staples

Raia Drogasil is one of Brazil’s largest pharmacy chains. It sells prescription medicines, over-the-counter drugs, health and personal care products, beauty items, and everyday convenience goods through its stores and online channels. Its main customers are ordinary consumers who need to fill prescriptions, buy treatments for common ailments, or pick up routine household and personal care items.

Headquarters
Brazil BR
Employees
75 190
IPO date
Oct 20, 2010
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Raia Drogasil S/A

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one RADLY stock?

The intrinsic value for Raia Drogasil S/A (RADLY) under the Base Case is 4.45 USD.

Is RADLY stock undervalued or overvalued?

Compared with the current market price of 2.7 USD, the stock appears Undervalued by 39% .

Back to Top